chr2-32147216-A-G

Variant names:

• chr2-32147216-A-G
• rs587777752
• NM_014946.4:c.1688-2A>G

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1 PM2 PP5_Very_Strong

The NM_014946.4(SPAST):​c.1688-2A>G variant causes a splice acceptor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).

• Frequency: Genomes: not found (cov: 31)
• Consequence: SPAST NM_014946.4 splice_acceptor, intron
• Scores: Splicing: ADA: 1.000
• Clinical Significance: Pathogenic criteria provided, multiple submitters, no conflicts P:4
• Conservation: PhyloP100: 6.71
• Publications: 1 publications found

Genes affected

SPAST (HGNC:11233): (spastin) This gene encodes a member of the AAA (ATPases associated with a variety of cellular activities) protein family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. The use of alternative translational initiation sites in this gene results in a single transcript variant that can produce isoforms that differ in the length of their N-terminus and which thereby differ in the efficiency of their export from the nucleus to the cytoplasm. In addition, alternative splicing results in multiple transcript variants that encode isoforms that differ in other protein regions as well. One isoform of this gene has been shown to be a microtubule-severing enzyme that regulates microtubule abundance, mobility, and plus-end distribution. Mutations in this gene cause the most frequent form of autosomal dominant spastic paraplegia 4. [provided by RefSeq, May 2018]

SPAST Gene-Disease associations (from GenCC):

• hereditary spastic paraplegia 4

  Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Genomics England PanelApp, Ambry Genetics
• Charlevoix-Saguenay spastic ataxia

  Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
• neurodevelopmental disorder

  Inheritance: AD Classification: STRONG Submitted by: G2P
• SPAST-related motor disorder

  Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics

ACMG classification

Our verdict: Pathogenic. The variant received 18 ACMG points.

• PVS1: Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, Cryptic splice site detected, with MaxEntScore 4.4, offset of -23, new splice context is: aaaatgtatgtatttttaAGtgc. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
• PM2: Very rare variant in population databases, with high coverage
• PP5: Variant 2-32147216-A-G is Pathogenic according to our data. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-32147216-A-G is described in CliVar as Pathogenic. Clinvar id is 5661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
SPAST	NM_014946.4	c.1688-2A>G		splice_acceptor_variant, intron_variant	Intron 15 of 16	ENST00000315285.9	NP_055761.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
SPAST	ENST00000315285.9	c.1688-2A>G		splice_acceptor_variant, intron_variant	Intron 15 of 16	1	NM_014946.4	ENSP00000320885.3

Frequencies

GnomAD3 genomes Cov.: 31

GnomAD4 exome Cov.: 28

GnomAD4 genome Cov.: 31

ClinVar

Significance: Pathogenic

Submissions summary: Pathogenic:4

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

not provided Pathogenic:2

Sep 16, 2021

Athena Diagnostics

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is expected to severely impact normal RNA splicing, and consequently, protein structure and/or function. This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual with clinical features associated with this gene. In some published literature, this variant is referred to as c.1813-2A>G. -

Sep 01, 2018

CeGaT Center for Human Genetics Tuebingen

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Hereditary spastic paraplegia 4 Pathogenic:2

Jul 25, 2022

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 5661). Disruption of this splice site has been observed in individuals with hereditary spastic paraplegia (PMID: 10610178). This variant is not present in population databases (gnomAD no frequency). This sequence change affects an acceptor splice site in intron 15 of the SPAST gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in SPAST are known to be pathogenic (PMID: 20932283). For these reasons, this variant has been classified as Pathogenic. -

Nov 01, 1999

OMIM

Significance: Pathogenic

Review Status: no assertion criteria provided

Collection Method: literature only

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_addAF	Pathogenic	0.63	D
BayesDel_noAF	Pathogenic	0.32
CADD	Pathogenic	31
DANN	Uncertain	1.0
Eigen	Pathogenic	1.1
Eigen_PC	Pathogenic	0.98
FATHMM_MKL	Pathogenic	0.99	D
PhyloP100		6.7
GERP RS		5.6
Mutation Taster		=0/100	disease causing (ClinVar)

Splicing

Name	Calibrated prediction	Score	Prediction
dbscSNV1_ADA	Pathogenic	1.0
dbscSNV1_RF	Pathogenic	0.93
SpliceAI score (max)		0.98		Details are displayed if max score is > 0.2
DS_AL_spliceai		0.98		Position offset: 2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs587777752; hg19: chr2-32372285;